Barclays raised the firm’s price target on Unum Group to $52 from $46 and keeps an Equal Weight rating on the shares. The analyst found last quarter’s comments about elevated mortality “to be a bit dubious” as higher seasonality was cited despite a pull forward of the flu season. The Q2 results for insurance companies “may serve as a cleaner quarter to determine if elevated mortality is on the rise,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on UNM: